SPC for darunavir considered invalid in Dutch preliminary relief proceedings
Biosimilars webinar series – Recent developments in biosimilars settlements, market landscape and antitrust scrutiny
Recent developments in biosimilars settlements, market landscape and antitrust scrutiny
Compensation scheme for employees who are long-term incapacitated for work takes effect from 1 April 2020
Taylor Wessing named European Trade Mark Firm of the Year at the MIP Global IP Awards 2019
Taylor Wessing announces partnership to help UK businesses grow globally
Taylor Wessing helps Secret Escapes Group expand in Europe
Supplementary protection certificates: where are we and where are we going? (an update)